Embecta (EMBC) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026)
Embecta (EMBC) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 18.75% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -203.74% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 10.48% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 56.10% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -190.91% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 23.62% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -112.00% |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | -117.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.50% |
| Sep 30, 2025 | 83.33% |
| Jun 30, 2025 | 212.00% |
| Mar 31, 2025 | -20.00% |
| Sep 30, 2024 | 140.00% |
| Jun 30, 2024 | -3.85% |
| Mar 31, 2024 | 108.33% |
| Dec 31, 2023 | -42.62% |
| Sep 30, 2023 | 140.00% |
| Jun 30, 2023 | -75.70% |
| Mar 31, 2023 | -82.61% |
| Dec 31, 2022 | -64.74% |
| Sep 30, 2022 | -114.04% |
| Jun 30, 2022 | -40.88% |
| Mar 31, 2022 | -26.20% |